EU Orphan Drug Launch – Understanding and delivering your EU Orphan Drug Launch
Launching your product on to the European Market can present a real challenge if you are not familiar with country specific requirements. In this eBook our expert orphan drug product launch team share their knowledge and experience regarding:
- The EU rare disease marketplace
- Regulatory / MA submission considerations
- Quality requirements – EU import testing and QP release
- Packaging design and regionalisation considerations
- Serialisation
- Almac’s Orphan Drug expertise
- Almac’s Seamless Brexit Solution
Submit the form below to access this eBook